{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:57:42Z","timestamp":1793642262132,"version":"4.5.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Tehran University of Medical Sciences to Prof. Shahin Akhondzadeh","award":["16043"],"award-info":[{"award-number":["16043"]}]}],"content-domain":{"domain":["psy-journal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.psychres.2015.07.043","type":"journal-article","created":{"date-parts":[[2015,7,16]],"date-time":"2015-07-16T23:13:45Z","timestamp":1437088425000},"page":"181-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism"],"prefix":"10.1016","volume":"229","author":[{"given":"Ali","family":"Ghaleiha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soudeh Mohebbi","family":"Rasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadali","family":"Nikoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Farokhnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Reza","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahin","family":"Akhondzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.psychres.2015.07.043_bib1","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.3390\/ph3061949","article-title":"Non-steroidal anti-inflammatory drugs and brain inflammation: effects on microglial functions","volume":"3","author":"Ajmone-Cat","year":"2010","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10.1016\/j.psychres.2015.07.043_bib2","first-page":"485","article-title":"The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects","volume":"89","author":"Aman","year":"1985","journal-title":"Am. J. Ment. Def."},{"issue":"1","key":"10.1016\/j.psychres.2015.07.043_bib3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00213-012-2796-8","article-title":"Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial","volume":"225","author":"Asadabadi","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psychres.2015.07.043_bib4","series-title":"Diagnostic criteria from DSM-IV-TR","author":"American Psychiatric Association","year":"2000"},{"issue":"4","key":"10.1016\/j.psychres.2015.07.043_bib5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.plefa.2004.03.008","article-title":"Essential fatty acids and phospholipase A2 in autistic spectrum disorders","volume":"71","author":"Bell","year":"2004","journal-title":"Prostaglandins Leukotriens Essen. Fatty Acids"},{"issue":"4","key":"10.1016\/j.psychres.2015.07.043_bib6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000079404","article-title":"Genetic, environmental and immunologic factors in the etiology of autism spectrum disorders","volume":"2","author":"B\u00f6lte","year":"2003","journal-title":"Neuroembryology"},{"issue":"3","key":"10.1016\/j.psychres.2015.07.043_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1742-2094-4-3","article-title":"Effect of pioglitazone treatment on behavioral symptoms in autistic children","volume":"4","author":"Boris","year":"2007","journal-title":"J. Neuroinflam."},{"key":"10.1016\/j.psychres.2015.07.043_bib8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0074-7742(05)71013-8","article-title":"Immunological findings in autism","volume":"71","author":"Cohly","year":"2005","journal-title":"Int. Rev. Neurobiol."},{"issue":"2","key":"10.1016\/j.psychres.2015.07.043_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neuint.2006.04.003","article-title":"Peroxisome proliferator-activated receptor agonist regulation of glial activation: Relevance to CNS inflammatory disorders","volume":"49","author":"Drew","year":"2006","journal-title":"Neurochem. Int."},{"issue":"3","key":"10.1016\/j.psychres.2015.07.043_bib10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.mehy.2007.01.018","article-title":"Pioglitazone as a therapeutic agent in autistic spectrum disorder","volume":"69","author":"Emanuele","year":"2007","journal-title":"Med. Hypotheses"},{"issue":"suppl 1","key":"10.1016\/j.psychres.2015.07.043_bib11","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.2337\/diabetes.53.2007.S43","article-title":"The biology of peroxisome proliferator-activated receptors relationship with lipid metabolism and insulin sensitivity","volume":"53","author":"Ferr\u00e9","year":"2004","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.psychres.2015.07.043_bib12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1177\/0269881113508830","article-title":"Galantamine efficacy and tolerability as an augmentative therapy in autistic children: a randomized, double-blind, placebo-controlled trial","volume":"28","author":"Ghaleiha","year":"2013","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.psychres.2015.07.043_bib13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s40272-013-0036-2","article-title":"Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trial","volume":"15","author":"Ghaleiha","year":"2013","journal-title":"Pediatric Drugs"},{"issue":"5","key":"10.1016\/j.psychres.2015.07.043_bib1001","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s10578-012-0292-3","article-title":"A double-blind placebo controlled trial of Ginkgo biloba added to risperidone in patients with autistic disorders","volume":"43","author":"Hasanzadeh","year":"2012","journal-title":"Child Psychiatry Hum. Dev."},{"issue":"4","key":"10.1016\/j.psychres.2015.07.043_bib14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1207\/S15374424JCCP2904_3","article-title":"Performance-based measures in autism: implications for diagnosis, early detection, and identification of cognitive profiles","volume":"29","author":"Klinger","year":"2000","journal-title":"J. Clin. Child Psychol."},{"issue":"2","key":"10.1016\/j.psychres.2015.07.043_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10673220802075852","article-title":"Pharmacological treatment options for autism spectrum disorders in children and adolescents","volume":"16","author":"Leskovec","year":"2008","journal-title":"Harv. Rev. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2015.07.043_bib17","doi-asserted-by":"crossref","first-page":"e1312","DOI":"10.1542\/peds.2011-0427","article-title":"A systematic review of medical treatments for children with autism spectrum disorders","volume":"127","author":"McPheeters","year":"2011","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.psychres.2015.07.043_bib18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/157488507780619095","article-title":"Autism spectrum disorders: etiology and pharmacotherapy","volume":"2","author":"Mohammadi","year":"2007","journal-title":"Curr. Drug Therapy"},{"issue":"6","key":"10.1016\/j.psychres.2015.07.043_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/WNF.0b013e3182a9339d","article-title":"Double-blind placebo-controlled trial of risperidone plus amantadine in children with autism: a 10-week randomized study","volume":"36","author":"Mohammadi","year":"2013","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.psychres.2015.07.043_bib20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.brainres.2012.03.036","article-title":"Abnormal microglial\u2013neuronal spatial organization in the dorsolateral prefrontal cortex in autism","volume":"1456","author":"Morgan","year":"2012","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.psychres.2015.07.043_bib21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pcl.2010.10.011","article-title":"Psychopharmacology of autistic spectrum disorders in children and adolescents","volume":"58","author":"Nazeer","year":"2011","journal-title":"Pediatric Clin. N. Am."},{"issue":"1","key":"10.1016\/j.psychres.2015.07.043_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/WNF.0000000000000063","article-title":"N-acetylcysteine as an adjunctive therapy to risperidone for treatment of irritability in autism: a randomized, double-blind, placebo-controlled clinical trial of efficacy and safety","volume":"38","author":"Nikoo","year":"2015","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.psychres.2015.07.043_bib23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.brainres.2006.04.108","article-title":"Ameliorative effect of pioglitazone on seizure responses in genetically epilepsy susceptible EL mice","volume":"1102","author":"Okada","year":"2006","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.psychres.2015.07.043_bib24","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1750-3639.2007.00102.x","article-title":"The neurobiology of autism","volume":"17","author":"Pardo","year":"2007","journal-title":"Brain Pathol."},{"issue":"7","key":"10.1016\/j.psychres.2015.07.043_bib25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.tins.2006.05.010","article-title":"Searching for ways out of the autism maze: genetic epigenetic and environmental clues","volume":"29","author":"Persico","year":"2006","journal-title":"Trends Neurosci."},{"issue":"2","key":"10.1016\/j.psychres.2015.07.043_bib26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1517\/14740331003623218","article-title":"Pioglitazone: side effect and safety profile","volume":"9","author":"Shah","year":"2010","journal-title":"Exp. Opin. Drug Saf."},{"key":"10.1016\/j.psychres.2015.07.043_bib27","first-page":"91","article-title":"The PPAR-\u03b3 agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys","volume":"5","author":"Swanson","year":"2011"},{"key":"10.1016\/j.psychres.2015.07.043_bib28","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1474-4422(02)00160-6","article-title":"Epilepsy in autism","volume":"1","author":"Tuchman","year":"2002","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.psychres.2015.07.043_bib29","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1007\/s10803-012-1513-0","article-title":"Microglia in the cerebral cortex in autism","volume":"42","author":"Tetreault","year":"2012","journal-title":"J. Autism Dev. Disord."},{"issue":"4","key":"10.1016\/j.psychres.2015.07.043_bib30","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.pneurobio.2008.04.006","article-title":"RAR\/RXR and PPAR\/RXR signaling in neurological and psychiatric diseases","volume":"85","author":"van Neerven","year":"2008","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.psychres.2015.07.043_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1054\/plef.2001.0281","article-title":"Plasma fatty acid levels in autistic children","volume":"65","author":"Vancassel","year":"2001","journal-title":"Prostaglandins Leukotriens Essen. Fatty Acids"},{"issue":"4","key":"10.1016\/j.psychres.2015.07.043_bib32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.plefa.2009.01.007","article-title":"Plasma fatty acid profiles in autism: a case-control study","volume":"80","author":"Wiest","year":"2009","journal-title":"Prostaglandins Leukotriens Essen. Fatty Acids"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178115005004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178115005004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T22:27:09Z","timestamp":1537482429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178115005004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":32,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0165178115005004"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2015.07.043","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2015.07.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}